Wall Street Journal: The human and physical logistics behind COVID vaccine rollouts
UC emergency medicine expert shares insight on how COVID-19 vaccines will be distributed
As states and hospitals in the United States race to roll out the first COVID-19 vaccines, the Wall Street Journal talked to a hospital administrator and immunization expert about the logistical challenges involved in this first phase of the vaccination process.
Dustin Calhoun, MD, of the Department of Emergency Medicine at the UC College of Medicine. Photo/Colleen Kelley/ UC Creative + Brand
University of Cincinnati Medical Center will be one of the locations distributing the Pfizer COVID-19 vaccine. Dustin Calhoun, MD, in the Department of Emergency Medicine at the UC College of Medicine, says in Ohio, the vaccine will be distributed in lots of 975 doses.
"The prepositioning sites will probably be receiving one package each initially, and then significantly larger amounts flowing after that," says Calhoun. "Any facility that needs a smaller amount than the 975 of the Pfizer vaccine, will be receiving it after it is re-processed through the state of Ohio into smaller lots of about 100 doses."
Calhoun says the initial rollout of the vaccine to frontline health care workers will help guide the process of giving it to the general population once the vaccine is more widely available.
Watch the full video report here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.